Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Elisei

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Journal of Endocrinological Investigation|January 15, 2005
Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scanC Ceccarelli, F Bianchi, D Trippi, et al.
Molecular and Cellular Endocrinology|June 16, 2009
Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acidA Vivaldi, F Y Miasaki, R Ciampi, et al.
Journal of Endocrinological Investigation|February 22, 2023
Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation testL Valerio, C Giani, A Matrone, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1994
Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinomaF Pacini, M Fontanelli, L Fugazzola, et al.
Molecular Endocrinology (Baltimore, Md.)|November 15, 2000
Conditional apoptosis induced by oncogenic ras in thyroid cellsJ M Shirokawa, R Elisei, J A Knauf, et al.
Journal of Endocrinological Investigation|July 22, 2021
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonatesL Lorusso, L Pieruzzi, M Gabriele, et al.
Molecular and Cellular Endocrinology|February 7, 2012
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell lineA Vivaldi, R Ciampi, A Tacito, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrenceC Romei, R Elisei, A Pinchera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2000
N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expressionF Basolo, F Pisaturo, L E Pollina, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|January 8, 2000
Thyroid consequences of the Chernobyl nuclear accidentF Pacini, T Vorontsova, E Molinaro, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Journal of Endocrinological Investigation|January 15, 2005
Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scanC Ceccarelli, F Bianchi, D Trippi, et al.
Molecular and Cellular Endocrinology|June 16, 2009
Re-differentiation of thyroid carcinoma cell lines treated with 5-Aza-2'-deoxycytidine and retinoic acidA Vivaldi, F Y Miasaki, R Ciampi, et al.
Journal of Endocrinological Investigation|February 22, 2023
Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation testL Valerio, C Giani, A Matrone, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1994
Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinomaF Pacini, M Fontanelli, L Fugazzola, et al.
Molecular Endocrinology (Baltimore, Md.)|November 15, 2000
Conditional apoptosis induced by oncogenic ras in thyroid cellsJ M Shirokawa, R Elisei, J A Knauf, et al.
Journal of Endocrinological Investigation|July 22, 2021
Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonatesL Lorusso, L Pieruzzi, M Gabriele, et al.
Molecular and Cellular Endocrinology|February 7, 2012
Celecoxib, a cyclooxygenase-2 inhibitor, potentiates the chemotherapic effect of vinorelbine in the medullary thyroid cancer TT cell lineA Vivaldi, R Ciampi, A Tacito, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrenceC Romei, R Elisei, A Pinchera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 26, 2000
N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expressionF Basolo, F Pisaturo, L E Pollina, et al.
Acta Paediatrica (Oslo, Norway : 1992). Supplement|January 8, 2000
Thyroid consequences of the Chernobyl nuclear accidentF Pacini, T Vorontsova, E Molinaro, et al.
Pageof 11